Testmate Health
Lausanne · Founded 2020
About Testmate Health
Testmate Health is a medtech startup and award-winning spin-off of University of Geneva (Switzerland). We have developed a smartphone compatible platform test kit that diagnoses any disease with an identifiable DNA or RNA sequence - without the need for a lab, providing results directly at home in minutes. Based on this platform, our first solution is the first rapid urine self-test for the four most common sexually transmitted diseases (STD). One million new STDs are diagnosed a day, and yet the best improvements to date still need a lab, with results taking up to 7 days to be ready. Our easy to use all-in-one-kit provides results in minutes, anywhere, at any time, and the result is scannable by a smartphone to enable people to immediately gain access to treatment – if needed. Further test-kits with other diseases are in the pipeline to empower users to skip the waiting room, and take charge of their health from home.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.8M
- Last round: Corporate Round (Dec 2025)
- Website: http://www.testmatehealth.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/testmate-health-120557 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.